This page shows ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN generates $6.89 in operating cash flow ($24.6B OCF vs $3.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN generated $47.7B in revenue in fiscal year 2025. This represents an increase of 12.7% from the prior year.
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN reported $3.6B in net income in fiscal year 2025. This represents an increase of 132.6% from the prior year.
Cash & Balance Sheet
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN held $231.0B in cash against $0 in long-term debt as of fiscal year 2025.
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN had 3.86B shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's net profit margin was 7.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.9 percentage points from the prior year.
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's ROE was 4.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.
Capital Allocation
SMHB Income Statement
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $11.6B-4.3% | $12.2B | N/A | $9.9B+8.7% | $9.1B | N/A | $8.5B |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | $37.0M+5.7% | $35.0M | N/A | $29.0M+31.8% | $22.0M | N/A | $25.0M |
| Income Tax | N/A | -$336.0M-210.9% | $303.0M | N/A | $28.0M-92.3% | $366.0M | N/A | $332.0M |
| Net Income | N/A | $1.2B+15.7% | $1.0B | N/A | -$224.0M-122.1% | $1.0B | N/A | $1.1B |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SMHB Balance Sheet
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.6T-3.3% | $1.7T+8.0% | $1.5T-1.3% | $1.6T+0.2% | $1.6T+40.1% | $1.1T-3.4% | $1.2T0.0% | $1.2T |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $231.0B-10.6% | $258.3B | N/A | $243.4B-12.3% | $277.5B | N/A | $190.5B+5.3% | $181.0B |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $6.6B-2.3% | $6.8B+0.9% | $6.7B+2.9% | $6.5B-7.4% | $7.0B+12.6% | $6.2B+4.0% | $6.0B-4.5% | $6.3B |
| Total Liabilities | $1.5T-3.1% | $1.6T+8.7% | $1.5T-1.6% | $1.5T+0.2% | $1.5T+38.5% | $1.1T-3.5% | $1.1T+5.5% | $1.0T |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $89.2B-6.0% | $94.9B-2.3% | $97.1B+2.6% | $94.7B+0.4% | $94.2B+70.2% | $55.4B-0.4% | $55.6B+4.3% | $53.3B |
| Retained Earnings | -$2.1B-158.0% | $3.7B-59.4% | $9.1B+16.5% | $7.8B+5.7% | $7.4B-74.6% | $29.2B+3.5% | $28.2B+1.5% | $27.8B |
SMHB Cash Flow Statement
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SMHB Financial Ratios
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | 10.3%+1.8pp | 8.5% | N/A | -2.3%-13.4pp | 11.1% | N/A | 13.3% |
| Return on Equity | N/A | 1.3%+0.2pp | 1.1% | N/A | -0.2%-2.1pp | 1.8% | N/A | 2.1% |
| Return on Assets | N/A | 0.1%0.0pp | 0.1% | N/A | -0.0%-0.1pp | 0.1% | N/A | 0.1% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 17.13+0.5 | 16.63+1.7 | 14.93-0.6 | 15.56-0.0 | 15.60-3.6 | 19.17-0.6 | 19.80+0.2 | 19.58 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's annual revenue?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) reported $47.7B in total revenue for fiscal year 2025. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's revenue growing?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) revenue grew by 12.7% year-over-year, from $42.3B to $47.7B in fiscal year 2025.
Is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN profitable?
Yes, ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) reported a net income of $3.6B in fiscal year 2025, with a net profit margin of 7.5%.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's net profit margin?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) had a net profit margin of 7.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's return on equity (ROE)?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) has a return on equity of 4.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's operating cash flow?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) generated $24.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's total assets?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) had $1.6T in total assets as of fiscal year 2025, including both current and long-term assets.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's debt-to-equity ratio?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) had a debt-to-equity ratio of 17.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's return on assets (ROA)?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) had a return on assets of 0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's Piotroski F-Score?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's earnings high quality?
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) has an earnings quality ratio of 6.89x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.